Developer of a synthetic peptide designed to provide treatment for benign skin tumors and various types of cancer. The company develops CyPep-1 peptide with a novel mechanism of action that guides the...

Healthcare
Bergen, Norway
Founded 2001
10 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$37.6M
Last Round
N/A

Get the full picture

Create a free account to unlock Cytovation's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required